Power of Attorney for Thomas A. Zalewski

This filing details a Power of Attorney granted by Thomas A. Zalewski, Chief Legal Officer of Aquestive Therapeutics, Inc., to Hillary T. Yegen, Ellen S. Knarr, and Christopher M. Rogers. The attorneys-in-fact are authorized to prepare and execute necessary documents for electronic SEC filings, including Forms 3, 4, 5, and 144, and to manage EDGAR account administration. This authorization allows the attorneys-in-fact to act on Mr. Zalewski's behalf for all reporting requirements under Section 16 of the Exchange Act and Rule 144. The Power of Attorney remains effective until Mr. Zalewski is no longer required to file these forms or until it is revoked in writing. The filing also notes that Mr. Zalewski, as reporting owner, currently holds 0 shares of Common Stock following the transaction.